Page de couverture de PayerTalkCE

PayerTalkCE

PayerTalkCE

Auteur(s): IMPACT
Écouter gratuitement

À propos de cet audio

 Learn about managed care policies and benefit designs from the health plan decision makers working to create them – and the clinicians who navigate them. PayerTalkCE brings you engaging discussions between payer and clinician experts on both specific conditions from atopic dermatitis to retinal disease as well as issues like social determinants of health and the impact of biosimilars. This unique look at health care in America features hosts from the cutting edge of managed care innovation and clinician experts from across the US. All PayerTalkCE podcasts are certified for free continuing education credit also, be sure to visit the show pages to earn yours.Copyright 2025 PayerTalkCE Éducation
Épisodes
  • PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers

    PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers
    Jun 18 2025
    In this episode of PayerTalkCE®, we will delve into the innovations around HER2-targeting therapies and their role in the treatment of select gastrointestinal cancers. Topics will include the latest evidence and the integration of new treatments into health care systems, insurance coverage, reimbursement challenges, and the overall impact on health care policy. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-cancer-management/.
    Voir plus Voir moins
    31 min
  • PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers

    PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers
    Jun 18 2025
    In this episode of PayerTalkCE® we will explore the epidemiology and burdens of gastroesophageal and biliary tract cancers. Experts will discuss the importance of early and accurate diagnosis in managing treatment efficacy and cost. The episode will also delve into the role of personalized medicine and multidisciplinary approaches and provide collaborative and actionable insights on how managed care professionals can adapt their strategies to better accommodate the complexities associated with rare GI cancers, ultimately aiming to enhance patient care while managing resource allocation effectively. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/gi-cancer-trends/.
    Voir plus Voir moins
    31 min
  • PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia

    PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia
    May 1 2025
    This podcast explores macular telangiectasia (MacTel), a rare and progressive retinal disease, with a focus on advancing early detection, appropriate treatment, and health system coordination. Retina specialist Dr. Jay Chhablani discusses the shift in understanding MacTel as a neurodegenerative—not vascular—condition, highlighting the limitations of anti-VEGF therapy and the significance of a newly approved, durable implant that targets neuroprotection. The discussion outlines the importance of benefit design that facilitates timely access, supports multidisciplinary care, and emphasizes early intervention to prevent irreversible vision loss. Practical payer strategies—including reducing artificial barriers and prioritizing education—are addressed to optimize outcomes. This activity is certified for CME/CNE/CPE credit. To participate and earn credit, visit us at https://www.impactedu.net/mactel-strategies-ce/.
    Voir plus Voir moins
    53 min
Pas encore de commentaire